Who is sponsoring NCT04423562?

NCT04423562 is sponsored by Rigshospitalet, Denmark.

What drugs are being tested in NCT04423562?

Interventions in NCT04423562: No intervention.

What condition does NCT04423562 study?

NCT04423562 studies Left Ventricular Assist Device, Prognosis, Advanced Heart Failure.

Is NCT04423562 still recruiting?

NCT04423562 is currently status unknown. Last updated 9 June 2020.

Last reviewed 2020-06-09 · How we verify

NCT04423562: PRO-VAD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PROgnostic Value of Exercise Capacity Measured as Peak Oxygen Uptake (pVO2) in Recipients of Left Ventricular Assist Devices

Status unknown Last updated 9 June 2020

What this trial tests

trial testing No intervention in Left Ventricular Assist Device in 500 participants. Status unknown.

Timeline

10 April 2020

Primary endpoint
31 December 2022

31 December 2022

Quick facts

Lead sponsor	Rigshospitalet, Denmark
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	500
Start date	10 April 2020
Primary completion	31 December 2022
Estimated completion	31 December 2022
Sites	1 location across Denmark

Drugs / interventions tested

No intervention

Conditions studied

Left Ventricular Assist Device — all drugs for Left Ventricular Assist Device →
Prognosis — all drugs for Prognosis →
Advanced Heart Failure — all drugs for Advanced Heart Failure →

Sponsor

Rigshospitalet, Denmark

Who can join

18 and older, any sex, with Left Ventricular Assist Device or Prognosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pooling of earlier VO2-studies conducted at the dept. of cardiology, Rigshospitalet, Denmark, and all LVAD centres of the World that wish to participate. The purpose is to investigate the prognostic value of VO2 in recipients of durable LVADs using data from studies already conducted.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Prognostic Value of Peak Oxygen Uptake in Patients Supported With Left Ventricular Assist Devices (PRO-VAD).
Mirza KK, Szymanski MK, Schmidt T, de Jonge N, et al · · 2021 · cited 26× · PMID 34391745 · DOI 10.1016/j.jchf.2021.05.021

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other recruiting trials for Left Ventricular Assist Device

Currently open trials in the same condition.

NCT06556485 — Preventive Catheter Ablation for Ventricular arrhythmiaS in Patients With End-sTage Heart faiLure · NA · recruiting
NCT07008729 — Heart Failure Patient Management and Interventions Using Continuous Patient Monitoring Outside Hospitals and Real-world · NA · active not recruiting
NCT04377854 — Prognostic Value of BNP in MCS - a 25 Year Follow up Study · recruiting

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

NCT07401368 — Clinicians' Trust in AI-Based Fetal Growth Estimates · NA · not yet recruiting
NCT07442357 — The Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial · NA · not yet recruiting
NCT07528729 — Alcohol as a Modifiable Risk Factor for Atrial Fibrillation · NA · not yet recruiting
NCT07511439 — Reversible Effects of Oral Contraceptive Removal on Serotonergic Neurotransmission · Phase 4 · not yet recruiting
NCT07467187 — Invasive Home Ventilation in Denmark · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04423562 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rigshospitalet, Denmark
Last refreshed: 9 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04423562.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing